Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Oltipraz chemoprevention trial in Qidong, People's Republic of China: modulation of serum aflatoxin albumin adduct biomarkers.

Kensler TW, He X, Otieno M, Egner PA, Jacobson LP, Chen B, Wang JS, Zhu YR, Zhang BC, Wang JB, Wu Y, Zhang QN, Qian GS, Kuang SY, Fang X, Li YF, Yu LY, Prochaska HJ, Davidson NE, Gordon GB, Gorman MB, Zarba A, Enger C, Muñoz A, Helzlsouer KJ, et al.

Cancer Epidemiol Biomarkers Prev. 1998 Feb;7(2):127-34.

2.

Oltipraz chemoprevention trial in Qidong, People's Republic of China: study design and clinical outcomes.

Jacobson LP, Zhang BC, Zhu YR, Wang JB, Wu Y, Zhang QN, Yu LY, Qian GS, Kuang SY, Li YF, Fang X, Zarba A, Chen B, Enger C, Davidson NE, Gorman MB, Gordon GB, Prochaska HJ, Egner PA, Groopman JD, Muñoz A, Helzlsouer KJ, Kensler TW.

Cancer Epidemiol Biomarkers Prev. 1997 Apr;6(4):257-65.

3.

Oltipraz chemoprevention trial in Qidong, Jiangsu Province, People's Republic of China.

Zhang BC, Zhu YR, Wang JB, Wu Y, Zhang QN, Qian GS, Kuang SY, Li YF, Fang X, Yu LY, De Flora S, Jacobson LP, Zarba A, Egner PA, He X, Wang JS, Chen B, Enger CL, Davidson NE, Gordon GB, Gorman MB, Prochaska HJ, Groopman JD, Muñoz A, Kensler TW.

J Cell Biochem Suppl. 1997;28-29:166-73. Review.

PMID:
9589363
4.

Elevations of hepatic quinone reductase, glutathione, and alpha- and mu-class glutathione S-transferase isoforms in mice with chronic hepatitis: a compensatory response to injury.

Fernandes CL, Dong JH, Roebuck BD, Chisari FV, Montali JA, Schmidt DE Jr, Prochaska HJ.

Arch Biochem Biophys. 1996 Jul 1;331(1):104-16.

PMID:
8660689
5.
6.

Inactivation of human immunodeficiency virus type 1 reverse transcriptase by oltipraz: evidence for the formation of a stable adduct.

Chavan SJ, Bornmann WG, Flexner C, Prochaska HJ.

Arch Biochem Biophys. 1995 Dec 1;324(1):143-52.

PMID:
7503549
7.
8.

Fluorometric measurement of reverse transcriptase activity with 4',6-diamidino-2-phenylindole.

Chavan SJ, Prochaska HJ.

Anal Biochem. 1995 Feb 10;225(1):54-9.

PMID:
7539986
9.

Oltipraz, a novel inhibitor of human immunodeficiency virus type 1 (HIV-1) replication.

Prochaska HJ, Chavan SJ, Baron P, Polsky B.

J Cell Biochem Suppl. 1995;22:117-25. Review.

PMID:
8538188
10.
12.
13.

Oltipraz, an inhibitor of human immunodeficiency virus type 1 replication.

Prochaska HJ, Yeh Y, Baron P, Polsky B.

Proc Natl Acad Sci U S A. 1993 May 1;90(9):3953-7.

14.

Chemoprotection by inducers of electrophile detoxication enzymes.

Kensler TW, Davidson NE, Groopman JD, Roebuck BD, Prochaska HJ, Talalay P.

Basic Life Sci. 1993;61:127-36. Review. No abstract available.

PMID:
8304925
15.

Rapid detection of inducers of enzymes that protect against carcinogens.

Prochaska HJ, Santamaria AB, Talalay P.

Proc Natl Acad Sci U S A. 1992 Mar 15;89(6):2394-8.

16.
17.

Induction of NAD(P)H:quinone reductase in human peripheral blood lymphocytes.

Gordon GB, Prochaska HJ, Yang LY.

Carcinogenesis. 1991 Dec;12(12):2393-6.

PMID:
1660793
18.

Regulation of enzymes that detoxify the electrophilic forms of chemical carcinogens.

Talalay P, Prochaska HJ, Spencer SR.

Princess Takamatsu Symp. 1990;21:177-87. Review.

PMID:
2134677
19.
21.
22.
26.

Preliminary crystallographic X-ray data for an NAD(P)H:quinone reductase from mouse liver.

Amzel LM, Bryant SH, Prochaska HJ, Talalay P.

J Biol Chem. 1986 Jan 25;261(3):1379.

27.
28.

On the mechanisms of induction of cancer-protective enzymes: a unifying proposal.

Prochaska HJ, De Long MJ, Talalay P.

Proc Natl Acad Sci U S A. 1985 Dec;82(23):8232-6.

29.

Specificity of induction of cancer protective enzymes by analogues of tert-butyl-4-hydroxyanisole (BHA).

Prochaska HJ, Bregman HS, De Long MJ, Talalay P.

Biochem Pharmacol. 1985 Nov 1;34(21):3909-14.

PMID:
4062966

Supplemental Content

Loading ...
Support Center